SlideShare a Scribd company logo
1 of 41
Chronic Leukemia
Dr Payal Desai
What is Leukemia ???
 Abnormal rapid monoclonal proliferation of
white blood cells in the blood and bone
marrow.
 Can be acute or chronic
 Can be Myeloid or Lymphoid
Topics that will be covered
 Chronic myeloid leukemia
 Chronic lymphocytic leukemia
- Definition
- Pathogenesis
- Clinical features
- Hematological changes
- Microscopic findings
- Immunophenotyping and genetics
Chronic Myeloid Leukemia (CML)
 It is clonal myeloproliferative neoplasm.
 Affected Age group: 25 – 60 years
 Peak in 4th and 5th decades
Common Pathogenesis
 Presence of mutated, constitutively activated
tyrosine kinases
leads to
growth factor–independent proliferation and
survival of marrow progenitors
4 Major myeloproliferative
neoplasms
 Chronic myeloid leukemia
 Polycythemia vera
 Primary myelofibrosis
 Essential thrombocythemia
Pathogenesis of CML
 CML is distinguished from other
myeloproliferative disorders by the presence
of a chimeric
BCR-ABL gene
t(9,22)
BCR gene on chromosome 22
ABL gene on chromosome 9
Philadelphia Chromosome
t(9;22) (q34;q11)- BCR-ABL fusion protein
The Philadelphia ( Ph’ ) chromosome: reciprocal translocation
Also found
- B ALL
- AML
Formation of Philadelphia
chromosome and BCR/ABL fusion gene
product
Clinical Features
 Insidious onset
 Initially – easy fatigability, weakness and weight loss
 Splenomegaly – dragging sensation on abdomen
 Accelerated phase – Increased anemia
- thrombocytopenia
 Blast crisis – Severe anemia
- multiple lymphadenopathis
- hepatosplenomegaly
Investigations
 Complete Blood Count
 Peripheral smear and bone marrow examination
 Flow cytometry
 Karyotyping
 FISH
 RT-PCR
Haematological changes
 Peripheral blood
 Marked leucocytosis Usually > 100,000/mm3
 Elevated myelocyte count
 Blasts usually <3%
 Basophilia
 Eosinophilia
 Monocytosis
 Thrombocytosis (300-1000 x 10^9/L)
Peripheral blood smear
 RBC – Normocytic normochromic cells with few
macrocytes
 WBC – Total count is markedly raised
Differential count shows increased neutrophils,
basophils and eosinophils
Myelocytes 20-40%
Blast cell <10%
 Platelets – Increased count
Peripheral blood smear
Eosinophil
Neutrophil
Basophil
Haematological changes
Bone marrow
100% cellularity
Myeloid precursors with
maturation
↑ megakaryocytes
Variable fibrosis
Immunophenotyping
 Tumor cells are positive for CD13, CD33,
CD41, CD14, CD117, CD34 and HLA-DR
 Detected by flow cytometry and IHC
Diagnosis of CML
 Complete Blood Count
 Peripheral smear and bone marrow
examination
 Karyotyping
 FISH
 RT-PCR
Targeted therapy
 BCR-ABL inhibitor, imatinib, results in
sustained hematologic remissions in greater
than 90% of patients
 Nilotinib
 Dasatinib
Chronic Lymphoid neoplasms
LYMPHOID NEOPLASMS
(WHO Classification)
 Precursor B-cell and T cell lymphoblastic
leukemia (ALL)
 Peripheral B-cell neoplasms (neoplasms of
mature B cells)
 Precursor T-cell neoplasms (neoplasms of
immature T cells)
 Peripheral T-cell and NK-cell neoplasms
(neoplasms of mature T cells and NK cells)
 Hodgkin lymphoma (neoplasms of Reed-Sternberg
cells and variants)
Chronic lymphocytic leukemia
 Chronic lymphocytic leukaemia (CLL) is a neoplastic disorder
characterised by monoclonal proliferation of mature B-
lymphocytes.
 Most common leukemia in adults of Western world
 Age affected > 50 years (median 60 years)
Pathogenesis
Increase activity of
B cell receptor
(BCR)
Survival and
proliferation of B
cells
Clinical features
 Mostly nonspecific
 Easy fatigability
 Weight loss
 Generalized lymphadenopathy and
hepatosplenomegaly (50-60%)
 Increased susceptibility to infections
(hypogammaglobulinemia)
Investigations
 Complete Blood Count
 Peripheral smear and bone marrow examination
 Flow cytometry
 Karyotyping
 FISH
 RT-PCR
Haematological findings
B cell lymphocytosis (> 5 x 10^9/L)
>90% cells are lymphocytes in smear
Bone marrow: - increased cellularity
- >30% lymphocytes
- decreased normal
hemopoietic precursors
Peripheral blood smear
 RBC – Normocytic normochromic
(May show presence of spherocytes)
 WBC – Total count is markedly raised
Differential count shows lymphocytosis
Smudge cells are seen
 Platelets – Adequate
(may decrease in advanced cases)
Immunophenotyping
 Tumor cells are positive for
 CD19
 CD23
 CD5
 CD 27
Quick revision
 What is Leukemia ?
 What are myeloproliferative neoplasms ? Name 4
 What is the pathogenesis of CML ?
 What are the phases of CML ?
 What investigations can be done in CML/CLL ?
 Peripheral smear findngs of CML
 WHO classification of lymphoid neoplasms
 What are the peripheral smear findings of CLL ?
Write the PBF for this smear
Write the PBF for this smear
Chronic leukemias basic overview    .ppt

More Related Content

Similar to Chronic leukemias basic overview .ppt

Haematological Malignancies
Haematological MalignanciesHaematological Malignancies
Haematological Malignanciesmeducationdotnet
 
Hematology (1) The blood and bone marrow, abnormal blood count, anemias: an o...
Hematology (1) The blood and bone marrow, abnormal blood count, anemias: an o...Hematology (1) The blood and bone marrow, abnormal blood count, anemias: an o...
Hematology (1) The blood and bone marrow, abnormal blood count, anemias: an o...Ahmed Elshebiny
 
Leukemia,mds,myeloproliferative
Leukemia,mds,myeloproliferativeLeukemia,mds,myeloproliferative
Leukemia,mds,myeloproliferativeHasiburRahman82
 
R PPT to Present-1ddddddddddddddddddddd.pptx
R PPT to Present-1ddddddddddddddddddddd.pptxR PPT to Present-1ddddddddddddddddddddd.pptx
R PPT to Present-1ddddddddddddddddddddd.pptxdmfrmicro
 
pancytopenia-170119201048.pdf
pancytopenia-170119201048.pdfpancytopenia-170119201048.pdf
pancytopenia-170119201048.pdfmergawekwaya
 
Lukemia in children
Lukemia in children Lukemia in children
Lukemia in children ChinchuBalan
 
Acute leukemia lm754
Acute leukemia lm754Acute leukemia lm754
Acute leukemia lm754Ahmad Qudah
 
Haematological malignancies CML.pptx
Haematological malignancies  CML.pptxHaematological malignancies  CML.pptx
Haematological malignancies CML.pptxHassan25409
 
acute and chronic Leukemia therapy by irfan hamid
 acute and chronic Leukemia  therapy by irfan hamid acute and chronic Leukemia  therapy by irfan hamid
acute and chronic Leukemia therapy by irfan hamidayeshahmed786
 
complete blood count.ppt
complete blood count.pptcomplete blood count.ppt
complete blood count.pptSakar Ahmed
 
chronic leukemia.pptx
chronic leukemia.pptxchronic leukemia.pptx
chronic leukemia.pptxNatanA7
 
Aml and all by asif.ppt.jjj
Aml and all by asif.ppt.jjjAml and all by asif.ppt.jjj
Aml and all by asif.ppt.jjjAsif Zeb
 
HAEMATOLOGICAL TESTS.docx
HAEMATOLOGICAL TESTS.docxHAEMATOLOGICAL TESTS.docx
HAEMATOLOGICAL TESTS.docxNbkKarim1
 
Leukemias-basic pathology
Leukemias-basic pathologyLeukemias-basic pathology
Leukemias-basic pathologyjaiminmanek4
 

Similar to Chronic leukemias basic overview .ppt (20)

Cml1
Cml1Cml1
Cml1
 
No Title
No TitleNo Title
No Title
 
No Title
No TitleNo Title
No Title
 
Haematological Malignancies
Haematological MalignanciesHaematological Malignancies
Haematological Malignancies
 
No Title
No TitleNo Title
No Title
 
Hematology (1) The blood and bone marrow, abnormal blood count, anemias: an o...
Hematology (1) The blood and bone marrow, abnormal blood count, anemias: an o...Hematology (1) The blood and bone marrow, abnormal blood count, anemias: an o...
Hematology (1) The blood and bone marrow, abnormal blood count, anemias: an o...
 
leukemia.pptx
leukemia.pptxleukemia.pptx
leukemia.pptx
 
Leukemia,mds,myeloproliferative
Leukemia,mds,myeloproliferativeLeukemia,mds,myeloproliferative
Leukemia,mds,myeloproliferative
 
R PPT to Present-1ddddddddddddddddddddd.pptx
R PPT to Present-1ddddddddddddddddddddd.pptxR PPT to Present-1ddddddddddddddddddddd.pptx
R PPT to Present-1ddddddddddddddddddddd.pptx
 
Pancytopenia
PancytopeniaPancytopenia
Pancytopenia
 
pancytopenia-170119201048.pdf
pancytopenia-170119201048.pdfpancytopenia-170119201048.pdf
pancytopenia-170119201048.pdf
 
Lukemia in children
Lukemia in children Lukemia in children
Lukemia in children
 
Acute leukemia lm754
Acute leukemia lm754Acute leukemia lm754
Acute leukemia lm754
 
Haematological malignancies CML.pptx
Haematological malignancies  CML.pptxHaematological malignancies  CML.pptx
Haematological malignancies CML.pptx
 
acute and chronic Leukemia therapy by irfan hamid
 acute and chronic Leukemia  therapy by irfan hamid acute and chronic Leukemia  therapy by irfan hamid
acute and chronic Leukemia therapy by irfan hamid
 
complete blood count.ppt
complete blood count.pptcomplete blood count.ppt
complete blood count.ppt
 
chronic leukemia.pptx
chronic leukemia.pptxchronic leukemia.pptx
chronic leukemia.pptx
 
Aml and all by asif.ppt.jjj
Aml and all by asif.ppt.jjjAml and all by asif.ppt.jjj
Aml and all by asif.ppt.jjj
 
HAEMATOLOGICAL TESTS.docx
HAEMATOLOGICAL TESTS.docxHAEMATOLOGICAL TESTS.docx
HAEMATOLOGICAL TESTS.docx
 
Leukemias-basic pathology
Leukemias-basic pathologyLeukemias-basic pathology
Leukemias-basic pathology
 

Recently uploaded

SOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning PresentationSOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning Presentationcamerronhm
 
REMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptxREMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptxDr. Ravikiran H M Gowda
 
Food safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdfFood safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdfSherif Taha
 
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptxHMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptxmarlenawright1
 
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...Nguyen Thanh Tu Collection
 
Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and ModificationsMJDuyan
 
How to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptxHow to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptxCeline George
 
Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Jisc
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsMebane Rash
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxAreebaZafar22
 
Tatlong Kwento ni Lola basyang-1.pdf arts
Tatlong Kwento ni Lola basyang-1.pdf artsTatlong Kwento ni Lola basyang-1.pdf arts
Tatlong Kwento ni Lola basyang-1.pdf artsNbelano25
 
latest AZ-104 Exam Questions and Answers
latest AZ-104 Exam Questions and Answerslatest AZ-104 Exam Questions and Answers
latest AZ-104 Exam Questions and Answersdalebeck957
 
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptxCOMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptxannathomasp01
 
How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17Celine George
 
Plant propagation: Sexual and Asexual propapagation.pptx
Plant propagation: Sexual and Asexual propapagation.pptxPlant propagation: Sexual and Asexual propapagation.pptx
Plant propagation: Sexual and Asexual propapagation.pptxUmeshTimilsina1
 
Graduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - EnglishGraduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - Englishneillewis46
 
On_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptx
On_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptxOn_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptx
On_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptxPooja Bhuva
 
NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...
NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...
NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...Amil baba
 
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...Nguyen Thanh Tu Collection
 

Recently uploaded (20)

SOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning PresentationSOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning Presentation
 
REMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptxREMIFENTANIL: An Ultra short acting opioid.pptx
REMIFENTANIL: An Ultra short acting opioid.pptx
 
Food safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdfFood safety_Challenges food safety laboratories_.pdf
Food safety_Challenges food safety laboratories_.pdf
 
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptxHMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
HMCS Vancouver Pre-Deployment Brief - May 2024 (Web Version).pptx
 
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
 
Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and Modifications
 
How to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptxHow to setup Pycharm environment for Odoo 17.pptx
How to setup Pycharm environment for Odoo 17.pptx
 
Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
Tatlong Kwento ni Lola basyang-1.pdf arts
Tatlong Kwento ni Lola basyang-1.pdf artsTatlong Kwento ni Lola basyang-1.pdf arts
Tatlong Kwento ni Lola basyang-1.pdf arts
 
latest AZ-104 Exam Questions and Answers
latest AZ-104 Exam Questions and Answerslatest AZ-104 Exam Questions and Answers
latest AZ-104 Exam Questions and Answers
 
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptxCOMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
COMMUNICATING NEGATIVE NEWS - APPROACHES .pptx
 
How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17
 
Plant propagation: Sexual and Asexual propapagation.pptx
Plant propagation: Sexual and Asexual propapagation.pptxPlant propagation: Sexual and Asexual propapagation.pptx
Plant propagation: Sexual and Asexual propapagation.pptx
 
Graduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - EnglishGraduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - English
 
On_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptx
On_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptxOn_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptx
On_Translating_a_Tamil_Poem_by_A_K_Ramanujan.pptx
 
NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...
NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...
NO1 Top Black Magic Specialist In Lahore Black magic In Pakistan Kala Ilam Ex...
 
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
80 ĐỀ THI THỬ TUYỂN SINH TIẾNG ANH VÀO 10 SỞ GD – ĐT THÀNH PHỐ HỒ CHÍ MINH NĂ...
 

Chronic leukemias basic overview .ppt

  • 2. What is Leukemia ???  Abnormal rapid monoclonal proliferation of white blood cells in the blood and bone marrow.  Can be acute or chronic  Can be Myeloid or Lymphoid
  • 3.
  • 4. Topics that will be covered  Chronic myeloid leukemia  Chronic lymphocytic leukemia - Definition - Pathogenesis - Clinical features - Hematological changes - Microscopic findings - Immunophenotyping and genetics
  • 5. Chronic Myeloid Leukemia (CML)  It is clonal myeloproliferative neoplasm.  Affected Age group: 25 – 60 years  Peak in 4th and 5th decades
  • 6. Common Pathogenesis  Presence of mutated, constitutively activated tyrosine kinases leads to growth factor–independent proliferation and survival of marrow progenitors
  • 7.
  • 8. 4 Major myeloproliferative neoplasms  Chronic myeloid leukemia  Polycythemia vera  Primary myelofibrosis  Essential thrombocythemia
  • 9. Pathogenesis of CML  CML is distinguished from other myeloproliferative disorders by the presence of a chimeric BCR-ABL gene t(9,22) BCR gene on chromosome 22 ABL gene on chromosome 9
  • 10. Philadelphia Chromosome t(9;22) (q34;q11)- BCR-ABL fusion protein The Philadelphia ( Ph’ ) chromosome: reciprocal translocation Also found - B ALL - AML
  • 11. Formation of Philadelphia chromosome and BCR/ABL fusion gene product
  • 12. Clinical Features  Insidious onset  Initially – easy fatigability, weakness and weight loss  Splenomegaly – dragging sensation on abdomen  Accelerated phase – Increased anemia - thrombocytopenia  Blast crisis – Severe anemia - multiple lymphadenopathis - hepatosplenomegaly
  • 13.
  • 14. Investigations  Complete Blood Count  Peripheral smear and bone marrow examination  Flow cytometry  Karyotyping  FISH  RT-PCR
  • 15. Haematological changes  Peripheral blood  Marked leucocytosis Usually > 100,000/mm3  Elevated myelocyte count  Blasts usually <3%  Basophilia  Eosinophilia  Monocytosis  Thrombocytosis (300-1000 x 10^9/L)
  • 16. Peripheral blood smear  RBC – Normocytic normochromic cells with few macrocytes  WBC – Total count is markedly raised Differential count shows increased neutrophils, basophils and eosinophils Myelocytes 20-40% Blast cell <10%  Platelets – Increased count
  • 18.
  • 19. Haematological changes Bone marrow 100% cellularity Myeloid precursors with maturation ↑ megakaryocytes Variable fibrosis
  • 20.
  • 21.
  • 22. Immunophenotyping  Tumor cells are positive for CD13, CD33, CD41, CD14, CD117, CD34 and HLA-DR  Detected by flow cytometry and IHC
  • 23. Diagnosis of CML  Complete Blood Count  Peripheral smear and bone marrow examination  Karyotyping  FISH  RT-PCR
  • 24. Targeted therapy  BCR-ABL inhibitor, imatinib, results in sustained hematologic remissions in greater than 90% of patients  Nilotinib  Dasatinib
  • 25.
  • 27. LYMPHOID NEOPLASMS (WHO Classification)  Precursor B-cell and T cell lymphoblastic leukemia (ALL)  Peripheral B-cell neoplasms (neoplasms of mature B cells)  Precursor T-cell neoplasms (neoplasms of immature T cells)  Peripheral T-cell and NK-cell neoplasms (neoplasms of mature T cells and NK cells)  Hodgkin lymphoma (neoplasms of Reed-Sternberg cells and variants)
  • 28.
  • 29. Chronic lymphocytic leukemia  Chronic lymphocytic leukaemia (CLL) is a neoplastic disorder characterised by monoclonal proliferation of mature B- lymphocytes.  Most common leukemia in adults of Western world  Age affected > 50 years (median 60 years)
  • 30. Pathogenesis Increase activity of B cell receptor (BCR) Survival and proliferation of B cells
  • 31. Clinical features  Mostly nonspecific  Easy fatigability  Weight loss  Generalized lymphadenopathy and hepatosplenomegaly (50-60%)  Increased susceptibility to infections (hypogammaglobulinemia)
  • 32. Investigations  Complete Blood Count  Peripheral smear and bone marrow examination  Flow cytometry  Karyotyping  FISH  RT-PCR
  • 33. Haematological findings B cell lymphocytosis (> 5 x 10^9/L) >90% cells are lymphocytes in smear Bone marrow: - increased cellularity - >30% lymphocytes - decreased normal hemopoietic precursors
  • 34. Peripheral blood smear  RBC – Normocytic normochromic (May show presence of spherocytes)  WBC – Total count is markedly raised Differential count shows lymphocytosis Smudge cells are seen  Platelets – Adequate (may decrease in advanced cases)
  • 35.
  • 36.
  • 37. Immunophenotyping  Tumor cells are positive for  CD19  CD23  CD5  CD 27
  • 38. Quick revision  What is Leukemia ?  What are myeloproliferative neoplasms ? Name 4  What is the pathogenesis of CML ?  What are the phases of CML ?  What investigations can be done in CML/CLL ?  Peripheral smear findngs of CML  WHO classification of lymphoid neoplasms  What are the peripheral smear findings of CLL ?
  • 39. Write the PBF for this smear
  • 40. Write the PBF for this smear

Editor's Notes

  1. Abnormality discovered by Peter Nowell and David Hungerford in 1960, region, band and sub band